CA2318279A1 - Analgesic from snake venom - Google Patents

Analgesic from snake venom Download PDF

Info

Publication number
CA2318279A1
CA2318279A1 CA002318279A CA2318279A CA2318279A1 CA 2318279 A1 CA2318279 A1 CA 2318279A1 CA 002318279 A CA002318279 A CA 002318279A CA 2318279 A CA2318279 A CA 2318279A CA 2318279 A1 CA2318279 A1 CA 2318279A1
Authority
CA
Canada
Prior art keywords
fraction
venom
analgesic
xanthina
vipera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002318279A
Other languages
English (en)
French (fr)
Inventor
Aharon Shulov (Deceased)
Naftali Primor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHULOV INSTITUTE FOR VENOM RESEARCH Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2318279A1 publication Critical patent/CA2318279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002318279A 1998-01-20 1999-01-13 Analgesic from snake venom Abandoned CA2318279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL123001 1998-01-20
IL12300198A IL123001A (en) 1998-01-20 1998-01-20 Analgesic fraction from snake March and pharmacy preparations containing it
PCT/IL1999/000020 WO1999036078A1 (en) 1998-01-20 1999-01-13 Analgesic from snake venom

Publications (1)

Publication Number Publication Date
CA2318279A1 true CA2318279A1 (en) 1999-07-22

Family

ID=11071113

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002318279A Abandoned CA2318279A1 (en) 1998-01-20 1999-01-13 Analgesic from snake venom

Country Status (9)

Country Link
US (1) US6555109B1 (ja)
EP (1) EP1049479B1 (ja)
JP (1) JP2002509110A (ja)
AT (1) ATE309811T1 (ja)
AU (1) AU754119B2 (ja)
CA (1) CA2318279A1 (ja)
DE (1) DE69928375T2 (ja)
IL (1) IL123001A (ja)
WO (1) WO1999036078A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208150B1 (en) 1999-07-14 2007-04-24 S.I.S. Shulov Institute For Science Ltd. Analgesic from snake venom
SE0003619L (sv) * 1999-12-28 2001-08-23 Bjoern Oertenheim Farmaceutisk komposition och metod för dess framställning
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
AU2005239771B2 (en) 2004-05-06 2011-03-10 Yara Cury Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes
US20060034823A1 (en) * 2004-08-13 2006-02-16 Paul Reid Method of production and use of crotoxin as an analgesic
ATE506069T1 (de) * 2004-08-16 2011-05-15 Medical Res Fund At The Tel Aviv Sourasky Medical Ct Verfahren und zusammensetzung zur modulation des systemischen entzündlichen reaktionssyndroms (sirs)
US20060234934A1 (en) * 2005-04-15 2006-10-19 Kilmon Joseph A Composition and Method for Selective Cytostasis
US7444605B2 (en) * 2005-10-06 2008-10-28 Synopsys, Inc. Generating a base curve database to reduce storage cost
US20070148159A1 (en) * 2005-12-22 2007-06-28 Reid Paul F Use of crotoxin as an analgesic - CIP
ES2598829T3 (es) 2011-03-28 2017-01-30 S.I.S. Shulov Innovative Science Ltd. Procedimiento de tratamiento de trastornos cutáneos
WO2016145256A1 (en) * 2015-03-10 2016-09-15 Reid Paul F Use of components of cobra venom for treatment of chronic kidney disease
KR102340534B1 (ko) * 2019-07-02 2021-12-21 독립바이오제약(주) Naja melanoleuca로부터 유래된 뱀독을 포함하는 류마티스 관절염의 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU435824A1 (ja) 1972-08-15 1974-07-15 Н. Б. Шоттер, А. Я. Синка, О. Л. вээ , А. Ф. Раков Тал инский химико фармацевтический завод
FR2578745B1 (fr) * 1985-03-18 1989-05-12 Berdal Pascal Preparations pharmaceutiques fluidifiant le sang
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
WO1991001740A1 (en) 1989-08-05 1991-02-21 Varánusz Gm Process for producing pharmacosmetics
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms

Also Published As

Publication number Publication date
IL123001A0 (en) 1998-08-16
IL123001A (en) 1998-12-06
EP1049479A4 (en) 2003-04-09
JP2002509110A (ja) 2002-03-26
EP1049479B1 (en) 2005-11-16
ATE309811T1 (de) 2005-12-15
DE69928375T2 (de) 2006-08-10
EP1049479A1 (en) 2000-11-08
WO1999036078A1 (en) 1999-07-22
AU1888799A (en) 1999-08-02
DE69928375D1 (de) 2005-12-22
US6555109B1 (en) 2003-04-29
AU754119B2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
Tatemoto et al. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin
KR100378787B1 (ko) 항-맥관형성활성과종양퇴화효과를갖는상어의연골추출물및그의제조방법
EP1049479B1 (en) Analgesic from snake venom
DE69130289T2 (de) Therapeutische verwendung von actin-bindenden verbindungen
KR100347880B1 (ko) 상어연골추출물,그의제조방법및용도
Palmour et al. Characterization of a peptide from the serum of psychotic patients
EP0348353A2 (en) The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases
Teixeira et al. Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea‐pig skin
DE3587526T2 (de) Serinproteaseinhibitoren und isolierungsverfahren dazu.
US7208150B1 (en) Analgesic from snake venom
Osipov et al. Effects of snake venom polypeptides on central nervous system
Kapoor Natural toxins and their therapeutic potential
Talukdar et al. Snake venom toxins targeting the central nervous system
US20070148159A1 (en) Use of crotoxin as an analgesic - CIP
Zetler Biologically active peptides (substance P)
Andersson et al. ACE inhibitors and their influence on inflammation, bronchial reactivity and cough
Wilson et al. Tx: A component in human dialyzable transfer factor that induces cutaneous delayed hypersensitivity in guinea pigs
Gomes et al. Occurrence of a unique protein toxin from the Indian King Cobra (Ophiophagus hannah) venom
Fan et al. A suppressive protein generated in peripheral lymph tissue induced by restraint stress
Crosland Effect of drugs on the lethality in mice of the venoms and neurotoxins from sundry snakes
KR0156623B1 (ko) 상피세포 손상 치료용 조성물
GB2056993A (en) Anorexogenic substance
WO2010138024A2 (ru) Средство для защиты клеток мозга
Ohanme et al. Extract of Celosia leptostachya Leaves Inhibits Cobra Venom Toxins
US10004778B1 (en) Method of making an Ajwa date-based treatment for snake envenomation

Legal Events

Date Code Title Description
FZDC Discontinued application reinstated
EEER Examination request
FZDE Discontinued